Disease and drug interactions: Treating malaria with artesunate plus amodiaquine in patients also receiving treatment for concomitant HIV infection

Clinical Infectious Diseases

Volumn 46, Issue 7, 2008, Pages 992-993

  Olliaro, Piero ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ANTIVIRUS AGENT; ARTESUNATE; COTRIMOXAZOLE; ZIDOVUDINE;

DOSE RESPONSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; MALARIA; MIXED INFECTION; MORBIDITY; MORTALITY; NEUTROPENIA; NOTE; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL;

AMODIAQUINE; ANTI-HIV AGENTS; ANTIMALARIALS; ARTEMISININS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MALARIA; NEUTROPENIA; SESQUITERPENES;

EID: 42549152976     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/529193     Document Type: Note

References (2)

1. Gasasira AF, Kamya MR, Achan J, Mebrahtu T, et al. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. Clin Infect Dis 2008; 46:985-91 (in this issue).
2. World Health Organization. Malaria and HIV interactions and their implications for public health policy. 2008. Available at: http://www.who.int/hiv/pub/prev_care/malaria/en/. Accessed 7 December 2007.